Skip to content

Study of pain relief effect with addition of Dexmedetomidine to Ropivacaine in Paravertebral Block in kidney surgeries in children.

Evaluation Of Analgesic Efficacy Of Dexmedetomidine As An Adjuvant To Ropivacaine in Paravertebral Block in Renal Surgeries in Paediatric Population: A Randomized Clinical Trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/068090
Enrollment
40
Registered
2024-05-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Paravertebral block with Ropivacaine plus Dexmedetomidine.: We will be putting paravertebral block with ropivacaine (0.5 ml/kg) plus dexmedetomidine( 1mcg /kg) in test group. -Dose of

Sponsors

Chacha Nehru Bal Chikitsalaya
Lead Sponsor
Chacha Nehru Bal Chikitsalaya
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1) Children aged 2-12 years undergoing renal surgeries. 2) ASA physical status grade I and II.

Exclusion criteria

Exclusion criteria: 1) any contraindications for paravertebral block ( infection at the injection site, kyphoscoliosis, history of bleeding disorders,patients on anticoagulants,history of drug allergy.) 2) Patients on chronic analgesics.

Design outcomes

Primary

MeasureTime frame
Time to first rescue analgesic requirement in the postoperative period.Timepoint: First 24 hours in post operative period.

Secondary

MeasureTime frame
1. Total consumption of analgesics in postoperative period for 24 hours. 2. Intraoperative opioid consumption. 3. Pain scores in the postoperative period for 24 hours. 4. Satisfaction score for pain relief - good /average /poor. 5. Untoward effects if any - hypotension, bradycardia, sedation, vomiting, pneumothorax. Timepoint: First 24 hours in post operative period

Countries

India

Contacts

Public ContactBhumika Kalra

Chacha Nehru Bal Chikitsalaya

drsinjini.02@gmail.com9177855898

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026